LIVE NOW /
Watch News Channel 8 on Great 38

Sanofi recalls heartburn medication Zantac

Health News

TAMPA, Fla. (CNN/AP) – Drugmaker Sanofi is voluntarily recalling the heartburn medication Zantac OTC that is being sold in the United States and Canada.

This recall is being taken due to possible contamination with a nitrosamine impurity called N-nitrosodimethylamine (NDMA). The company is working with health authorities to determine the level and extent of the recall.

In September, N-nitrosodimethylamine, or NDMA, was considered a possible carcinogen by the US Environmental Protection Agency, the FDA and Health Canada. NDMA can be unintentionally introduced into manufacturing through certain chemical reactions.

Sanofi encourages anyone using Zantac OTC to speak with their health care providers or pharmacists if they have any additional questions.

LATEST STORIES:

Copyright 2021 Nexstar Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Trending Stories

get the app

News App

Weather App

Don't Miss

More Don't Miss